Other languages Orthocell Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:16 2024-05-07 am EDT			5-day change	1st Jan Change
0.375 ^AUD	-3.85%		-1.32%	-8.54%

Apr. 15	Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3%	MT
Apr. 09	Orthocell Revenue Soars 19% to AU$1.61 Million in Q1	MT

Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3%	Apr. 14
Orthocell Revenue Soars 19% to AU$1.61 Million in Q1	Apr. 08
Orthocell Completes First Stage of Remplir US Market Authorization Study	Mar. 24
Orthocell Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22
Orthocell Completes AU$3.5 Million Share Placement	Feb. 21
Orthocell Submits Regulatory Application for Remplir in Singapore	Feb. 12
Orthocell Limited Announces Resignation of Matthew Callahan from the Board	Jan. 15
Orthocell Limited Appoints Kim Beazley AC as an Independent Non-Executive Director	Jan. 14
Orthocell Limited Announces Changes to its Board	Dec. 21
Orthocell Limited Provides Commercial Revenue Guidance for the Full Year 2023	23-10-24
Orthocell Limited Announces Board Changes	23-10-24
Orthocell Limited Announces Board Changes	23-09-21
Orthocell Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31
Orthocell Limited Announces Board Changes	23-05-28
Orthocell Begins Comparator Study for Product Marketing Initiatives	23-04-17
Orthocell Limited Announces Appointments to its Medical and Scientific Advisory Board	23-03-28
Orthocell Limited Appoints Ravi I. Thadhani as Independent Non-Executive Director	23-03-07
Orthocell Announces Company Secretary Changes	23-02-28
Orthocell Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-28
Orthocell's Nerve Repair Product Joins Australian Prosthesis Reimbursement List	22-10-31

No results for this search